SGRY News and Press, Surgery Partners Inc. From 02/02/22

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Strategy outperformance in the quarter and the year was d...

BRENTWOOD, Tenn., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Members of management of Surgery Partners, Inc. (NASDAQ: SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, will be meeting with investors today, January 10, 2022, as part of the 40th An...

Stifel has upgraded Surgery Partners (SGRY +3.2%) to buy from hold given the company's organic growth, expenser management, and improvement in investment and balance sheet. The firm has a price target of $51 (~17% upside). "We believe the secular trend of surgical procedures moving to ou...

BRENTWOOD, Tenn., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced the closing of its previously announced underwritten public offering of 6,900,000 shares of its common stock at a public offering price of $46.50 per ...

Surgery Partners (NASDAQ:SGRY) priced its earlier announced underwritten public offering of 6M shares at $46.5/share for expected gross proceeds of ~$279M. Underwriters granted 30-day option to purchase up to an additional 900K shares. Offer is expected to close on Nov.12. Net proceeds t...

BRENTWOOD, Tenn., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced the pricing of its previously announced underwritten public offering of 6,000,000 shares of its common stock at a public offering price of $46.50 per ...

Shares of Surgery Partners (SGRY +17.0%) are up today following Q3 2021 earnings results that beat analyst expectations and increasing 2021 guidance. The company now expects full-year adjusted EBITDA guidance increased of $325M to $330M. It also projects 2021 revenues to increase by 19% to 21...

Surgery Partners, Inc. (SGRY) Q3 2021 Earnings Conference Call November 2, 2021, 5:00 PM ET Company Participants Tom Cowhey - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Kevin Fischbeck - Bank of America Jason Ca...

Image source: The Motley Fool. Surgery Partners, inc (NASDAQ: SGRY) Q3 2021 Earnings Call Nov 2, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Surgery Partners, inc (SGRY) Q3 2021 Earnings Call Transcript

Surgery Partners (NASDAQ:SGRY): Q3 Non-GAAP EPS of -$0.05 beats by $0.05; GAAP EPS of -$0.28 misses by $0.10. Revenue of $559.2M (+12.7% Y/Y) beats by $13.33M. Press Release For further details see: Surgery Partners EPS beats by $0.05, beats on revenue